Scientists at MIT, the Albert Einstein College of Medicine and Weill Cornell Medical School have developed a test that could help doctors precisely identify which breast cancer patients should receive aggressive therapy, thereby sparing many women at low risk for metastatic disease from undergoing unnecessary and potentially dangerous treatment. The researchers, including MIT biology professor Frank Gertler, developed the test based on an earlier finding that the co-mingling of three cell types. (source: web.mit.edu)
|
